Search stocks

Find any stock by ticker or company name

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz haqimizda

Biz bilan bog'lanish

[email protected]

Bizni kuzating

Instagram
Telegram
LinkedIn

Barcha huquqlar himoyalangan.

Foydalanish shartlari

Bosh sahifa
Kuzatuv
Bozorlar
Kalendar
Skriner
Yangiliklar
Biz haqimizda

SRXH - SRX Global Inc. So'nggi Yangiliklar | Finranks

Home

/

SRXH

S

SRX Global Inc. (SRXH)

ASE – Real vaqt narxi. Valyuta: USD

1.82

-0.02 (-1.32%)

Bozor ochiq: Aug 12, 2026, 1:14 PM EDT

1.85

+0.01 (0.27%)

Oldingi bozordan keyin: Aug 11, 2026, 7:53 PM EDT

Umumiy
Yangiliklar
Grafik
Hisobotlar
Dividendlar
Kutilma
Egalik
Profil

SRX Global to Host Fiscal Third Quarter 2026 Conference Call on August 13 at 4:30 p.m. ET

SRX Global to Host Fiscal Third Quarter 2026 Conference Call on August 13 at 4:30 p.m. ET

NORTH PALM BEACH, Fla., Aug. 06, 2026 (GLOBE NEWSWIRE) -- SRX Global Inc. (NYSE American: SRXH) (the “Company”, or “SRX”), an AI-enabled platform dedicated to generating long-term shareholder value through investments in high-conviction operating companies and strategic assets, today announced that it plans to host a conference call and report its financial results for the fiscal third quarter ended June 30, 2026, on Thursday, August 13, 2026.

SRX Global Acquires Stake in Vistagen Therapeutics (NASDAQ: VTGN)

SRX Global Acquires Stake in Vistagen Therapeutics (NASDAQ: VTGN)

NORTH PALM BEACH, Fla., Aug. 04, 2026 (GLOBE NEWSWIRE) -- SRX Global Inc. (NYSE American: SRXH) (the “Company”, or “SRX”), an AI-enabled platform dedicated to generating long-term shareholder value through investments in high-conviction operating companies and strategic assets, today announced that it has acquired a stake in Vistagen Therapeutics, Inc. (Vistagen) (NASDAQ: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called pherines.

SRX Global Portfolio Company Smartkem, Inc. (NASDAQ: SMTK) Announces Merger

SRX Global Portfolio Company Smartkem, Inc. (NASDAQ: SMTK) Announces Merger

NORTH PALM BEACH, Fla., Aug. 03, 2026 (GLOBE NEWSWIRE) -- SRX Global Inc. (NYSE American: SRXH) (the “Company”, or “SRX”), an AI-enabled platform dedicated to generating long-term shareholder value through investments in high-conviction operating companies and strategic assets, today announced that its portfolio company Smartkem, Inc. (NASDAQ: SMTK), a leader in advanced materials, will merge with Ferrox Critical Minerals, strengthening its critical minerals sourcing.

Videolar

No Data

There is no data to display

Press-relizlar

SRX Global Acquires Stake in Vistagen Therapeutics (NASDAQ: VTGN)

SRX Global Acquires Stake in Vistagen Therapeutics (NASDAQ: VTGN)

NORTH PALM BEACH, Fla., Aug. 04, 2026 (GLOBE NEWSWIRE) -- SRX Global Inc. (NYSE American: SRXH) (the “Company”, or “SRX”), an AI-enabled platform dedicated to generating long-term shareholder value through investments in high-conviction operating companies and strategic assets, today announced that it has acquired a stake in Vistagen Therapeutics, Inc. (Vistagen) (NASDAQ: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called pherines.

SRX Global Portfolio Company Smartkem, Inc. (NASDAQ: SMTK) Announces Merger

SRX Global Portfolio Company Smartkem, Inc. (NASDAQ: SMTK) Announces Merger

NORTH PALM BEACH, Fla., Aug. 03, 2026 (GLOBE NEWSWIRE) -- SRX Global Inc. (NYSE American: SRXH) (the “Company”, or “SRX”), an AI-enabled platform dedicated to generating long-term shareholder value through investments in high-conviction operating companies and strategic assets, today announced that its portfolio company Smartkem, Inc. (NASDAQ: SMTK), a leader in advanced materials, will merge with Ferrox Critical Minerals, strengthening its critical minerals sourcing.